Wenping Gong Selected Research

Immunoglobulin G (IgG)

2/2015	Enhanced protection against Rickettsia rickettsii infection in C3H/HeN mice by immunization with a combination of a recombinant adhesin rAdr2 and a protein fragment rOmpB-4 derived from outer membrane protein B.
1/2015	Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenping Gong Research Topics

Disease

25	Tuberculosis (Tuberculoses) 11/2023 - 10/2017
11	Infections 10/2023 - 11/2013
8	COVID-19 10/2023 - 01/2021
4	Latent Tuberculosis 04/2023 - 01/2022
4	Communicable Diseases (Infectious Diseases) 10/2022 - 01/2018
4	Rocky Mountain Spotted Fever (Sao Paulo Typhus) 12/2017 - 01/2014
3	Spotted Fever Group Rickettsiosis (Rickettsialpox) 01/2016 - 11/2013
3	Q Fever (Fever, Q) 01/2015 - 01/2014
2	Coinfection 02/2023 - 01/2023
1	Latent Infection 04/2024
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Pathologic Processes 10/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 06/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Hyperglycemia 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Diabetes Mellitus 01/2022
1	Extensively Drug-Resistant Tuberculosis 09/2021
1	Virus Diseases (Viral Diseases) 01/2015
1	Necrosis 01/2015
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Brucellosis (Malta Fever) 12/2014
1	Mycoplasma Pneumonia 12/2014
1	Rickettsia Infections 01/2013

Drug/Important Bio-Agent (IBA)

22	VaccinesIBA 11/2023 - 01/2013
7	BCG Vaccine FDA Link 10/2023 - 01/2021
6	Peptides (Polypeptides)IBA 01/2022 - 01/2014
5	EpitopesIBA 04/2024 - 01/2014
4	Tuberculosis VaccinesIBA 01/2023 - 01/2020
4	AntigensIBA 01/2023 - 11/2013
4	Proteins (Proteins, Gene)FDA Link 02/2015 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2015 - 11/2013
2	DNA VaccinesIBA 01/2023 - 01/2019
2	CytokinesIBA 01/2023 - 01/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2017
2	Immunoglobulin G (IgG)IBA 02/2015 - 01/2015
1	MVA 85AIBA 11/2023
1	Interferon-gamma (Interferon, gamma)IBA 11/2023
1	Verapamil (Calan)FDA LinkGeneric 01/2023
1	CalciumIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	Sulfur DioxideIBA 10/2022
1	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 06/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Protective AgentsIBA 01/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 09/2021
1	Therapeutic UsesIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	MucinsIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	InterferonsIBA 01/2015
1	Subunit VaccinesIBA 12/2014
1	Recombinant ProteinsIBA 11/2013
1	Indicators and Reagents (Reagents)IBA 01/2013

Therapy/Procedure

3	Immunotherapy 10/2023 - 01/2021
2	Therapeutics 08/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2021